(WAVE) - Eli Lilly and Company, a pharmaceutical company headquartered in Indianapolis, plans to investment more at the LEAP Research and ... facility will be a new center for drug development ...

INDIANAPOLIS ... center for advanced manufacturing and drug development a few miles from its Indianapolis headquarters. The company said its Lilly Medicine Foundry will allow it to both research ...

Lilly announced on May 24 its additional investment to the LEAP District, including a new training facility in partnership with Purdue. LEAP is the midpoint along the Hard-Tech Corridor between Purdue ...

On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

Eli Lilly and Co.’s approval for Omvoh to treat moderate to severe Crohn’s disease in adults marks the Indianapolis company’s growing presence in the treatment of inflammatory bowel disease.

In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...

Eli Lilly and Co. announced Monday that it is buying Boston-based Scorpion Therapeutics and its targeted breast cancer treatment program in a deal worth up to $2.5 billion. The Indianapolis-based ...

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

Eli Lilly LLY-0.39%decrease ... sees healthy growth in 2025 due to the success of its weight-loss drugs. The Indianapolis-based pharmaceutical company said it expects fourth-quarter revenue ...